Government Contract Shifts Will Compound Uncertainty And Open IT Opportunities

Analysts have lifted the fair value estimate for Science Applications International to $96.13 from $86.80, reflecting updated views on its Q1 earnings beat, slightly lower discount rate assumptions, improved profit margin expectations, and revised P/E and revenue trajectories across a series of recent price target increases.

Analyst Commentary

Recent Street research on Science Applications International points to a mixed setup, with multiple firms lifting price targets after the Q1 earnings report while still flagging execution and growth risks that could limit upside. For readers, the key is less the absolute target level and more the reasoning behind cautious stances that sit alongside more constructive views.

Several firms describe Q1 as a strong or better than expected quarter and reference guidance that some see as achievable, yet not all are prepared to shift to a more positive rating. Neutral and Hold ratings remain common, even where targets have moved higher, which suggests that some analysts view the recent results as already reflected in the stock or balanced by potential headwinds.

There is also a range of opinion on Science Applications International's revenue trajectory and margin profile. Some analysts point to an upward bias to revenue estimates or guidance that could be conservative, while others explicitly flag the risk that certain Q1 margin levels may not be sustainable, especially in specific segments. This gap in views is an important signal for investors who are weighing how much of the Q1 performance can reasonably be extrapolated.

Another theme is the focus on contract risk and timing. Analysts referencing the Evolve recompete in the second half of fiscal 2027 and the delayed roll off of the RITS contract highlight concentration around key programs. These factors are being watched closely, as they can influence both top line visibility and margin trends, and they are part of the reason why some firms keep more cautious ratings despite higher price targets.

Even where targets are set above the current fair value estimate, several firms retain Neutral style ratings, including large banks such as JPMorgan. This mix of higher targets with neutral stances underscores that, while Q1 has been received as a positive data point, there is still debate about how much further upside is justified relative to execution, growth and contract renewal risks.

Bearish Takeaways

• Bearish analysts acknowledge the Q1 earnings beat but argue that parts of the Civil segment margin performance may not be sustainable, which could limit how much of the quarter's profitability should be capitalized into longer term valuation.
• Concerns around key contract events, including the Evolve recompete in the second half of fiscal 2027 and the delayed roll off of the RITS contract, are cited as potential pressure points for Science Applications International's growth and earnings visibility.
• Some bearish analysts maintain Hold or Neutral ratings even after raising price targets, signaling that, in their view, the stock already reflects much of the Q1 strength and should trade closer to group averages on metrics such as organic growth, margins, leverage and recompete performance.
• Large firms such as Goldman Sachs and JPMorgan, while lifting targets following Q1, still refrain from a more positive stance, which reinforces the idea that valuation upside is seen by some as constrained by execution risks and the need to prove that recent performance is repeatable.

What’s in the News for Science Applications International

• Science Applications International Corp. received a follow on US$50.6 million task order from the U.S. Navy’s Naval Undersea Warfare Center in Newport, Rhode Island, to continue work on torpedo defense system design, modernization, and sustainment services, leveraging digital engineering and advanced modeling and simulation capabilities. (Client Announcements)
• The company reported that from February 1, 2026 to May 1, 2026, it repurchased 1,875,172 shares for US$174.57 million, representing 4.26% of shares. This brought total repurchases under the buyback announced on December 5, 2024 to 6,569,338 shares, or 14.27%, for US$677.98 million. (Buyback Tranche Update)
• Science Applications International Corp. was awarded a new US$75.2 million task order under the General Services Administration Personnel and Readiness Infrastructure Support Management contract to support the Naval Air Systems Command with engineering and sustainment services for Aircraft Armament Equipment and Support Equipment, as well as the MQ-25 Stingray aerial refueling system. (Client Announcements)
• The company highlighted its role as a mission assurance partner for the successful Artemis II mission. It provided safety analysis, risk mitigation, integrated hazard analysis, and real time mission expertise for systems including the Space Launch System, Orion spacecraft, and crew survival over the mission. (Client Announcements)

Valuation Changes

• Fair Value: The fair value estimate for Science Applications International has risen from $86.80 to $96.13, reflecting updated assumptions across key inputs.
• Discount Rate: The discount rate has edged lower from 8.50% to 8.45%, a small change that increases the present value of projected cash flows.
• Revenue Growth: The long term revenue growth assumption now reflects a smaller decline, moving from a 2.02% decline to a 1.30% decline, which slightly reduces the expected headwind to the top line.
• Net Profit Margin: The net profit margin assumption has moved higher from 4.78% to 5.50%, indicating an expectation for somewhat stronger profitability in future years.
• Future P/E: The future P/E multiple used in the model has shifted from 12.7x to 10.8x, a lower terminal valuation multiple that partially offsets the impact of higher fair value drivers.